Article info

Download PDFPDF
Dominant Epstein–Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment
  1. Correspondence to Dr Thomas Daikeler, Department of Rheumatology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland; tdaikeler{at}uhbs.ch
View Full Text

Citation

Daikeler T, Hoenger G, Oehri I, et al
Dominant Epstein–Barr virus-specific T-cell responses are maintained during moderate and intense immunosuppressive treatment

Publication history

  • Accepted June 25, 2010
  • First published July 19, 2010.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.